Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies

Affiliations

• ¹ Laboratory of Investigative Dermatology, The Rockefeller University, NY, U.S.A.
• ² Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, Weill Cornell University, NY, U.S.A.
• ³ Department of Dermatology, Howard University, Washington, DC, U.S.A.
• ⁴ Department of Dermatology, Zucker School of Medicine at Hofstra Northwell, New Hyde Park, NY, U.S.A.
• ⁵ Institute of Infection & Immunity, Cardiff University, University Hospital of Wales, Cardiff, U.K.
• ⁶ Department of Dermatology, Penn State Hershey Medical Center, Hershey, PA, U.S.A.
• ⁷ Department of Dermatology, University of California, San Francisco, CA, U.S.A.
• ⁸ Division of Dermatology, Women's College Hospital, Toronto, ON, Canada.
• ⁹ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
• ¹⁰ Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.